The FDA has banned products from a Chinese API maker and suggested it get a consultant to direct upgrades after an inspection found serious problems in its manufacturing processes, some of which had ...
A Japanese API maker told the FDA that it had a “lack of awareness of the seriousness” of its GMP violations after admitting to the agency that it had manipulated data during its API testing. The ...
An arm of the private equity firm TPG will invest $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (APIs). Solara has five manufacturing sites and two research centers ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More On average, it costs $20,000 USD to build an application programming ...
Chinese AI firms try to win over OpenAI users with special offers as ChatGPT maker restricts API use
Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up China’s AI companies are rushing to win over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results